ClinicalThought

Share

Program Content

Activities

  • Using TRK Inhibitors
    How I Use TRK Inhibitors in Patients With NTRK Fusion–Positive Tumors
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: July 10, 2020

    Expires: July 09, 2021

Faculty

cover img faculity

Alexander E Drilon, MD

Chief, Early Drug Development Service
Memorial Sloan Kettering Cancer Center
New York, New York

Provided by

ProCE Banner

Supporters

Bayer Healthcare Pharma

Genentech TEXT Only